Dual targeting of aurora kinases with AMG 900 exhibits potent preclinical activity against acute myeloid leukemia with distinct post-mitotic outcomes

類似資料

• An Aurora kinase inhibitor, AMG900, inhibits glioblastoma cell proliferation by disrupting mitotic progression
  著者:: Ryu, Jaewook, 等
  出版事項: (2018)
• AMG 900, a potent inhibitor of aurora kinases causes pharmacodynamic changes in p-Histone H3 immunoreactivity in human tumor xenografts and proliferating mouse tissues
  著者:: Juan, Gloria, 等
  出版事項: (2014)
• A phase 1 study of AMG 900, an orally administered pan-aurora kinase inhibitor, in adult patients with acute myeloid leukemia
  著者:: Kantarjian, Hagop M., 等
  出版事項: (2017)
• Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer
  著者:: Paller, Channing J, 等
  出版事項: (2014)
• A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors
  著者:: Carducci, Michael, 等
  出版事項: (2018)